Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 62

1.

Catecholamine modulation of prefrontal cortical cognitive function.

Arnsten AF.

Trends Cogn Sci. 1998 Nov 1;2(11):436-47.

PMID:
21227275
2.

Influence of compulsivity of drug abuse on dopaminergic modulation of attentional bias in stimulant dependence.

Ersche KD, Bullmore ET, Craig KJ, Shabbir SS, Abbott S, Müller U, Ooi C, Suckling J, Barnes A, Sahakian BJ, Merlo-Pich EV, Robbins TW.

Arch Gen Psychiatry. 2010 Jun;67(6):632-44. doi: 10.1001/archgenpsychiatry.2010.60.

3.

The neuropsychopharmacology of fronto-executive function: monoaminergic modulation.

Robbins TW, Arnsten AF.

Annu Rev Neurosci. 2009;32:267-87. doi: 10.1146/annurev.neuro.051508.135535. Review.

4.

Dopamine receptors in human peripheral blood lymphocytes: changes in mRNA expression in opioid addiction.

Goodarzi A, Vousooghi N, Sedaghati M, Mokri A, Zarrindast MR.

Eur J Pharmacol. 2009 Aug 1;615(1-3):218-22. doi: 10.1016/j.ejphar.2009.04.060. Epub 2009 May 13.

PMID:
19445922
5.

Dopamine release in dissociable striatal subregions predicts the different effects of oral methylphenidate on reversal learning and spatial working memory.

Clatworthy PL, Lewis SJ, Brichard L, Hong YT, Izquierdo D, Clark L, Cools R, Aigbirhio FI, Baron JC, Fryer TD, Robbins TW.

J Neurosci. 2009 Apr 15;29(15):4690-6. doi: 10.1523/JNEUROSCI.3266-08.2009.

6.

Striatal dopamine predicts outcome-specific reversal learning and its sensitivity to dopaminergic drug administration.

Cools R, Frank MJ, Gibbs SE, Miyakawa A, Jagust W, D'Esposito M.

J Neurosci. 2009 Feb 4;29(5):1538-43. doi: 10.1523/JNEUROSCI.4467-08.2009.

7.

Genetics of dopamine receptors and drug addiction: a comprehensive review.

Le Foll B, Gallo A, Le Strat Y, Lu L, Gorwood P.

Behav Pharmacol. 2009 Feb;20(1):1-17. doi: 10.1097/FBP.0b013e3283242f05. Review.

PMID:
19179847
8.

Dopamine receptors in human lymphocytes: radioligand binding and quantitative RT-PCR assays.

Kirillova GP, Hrutkay RJ, Shurin MR, Shurin GV, Tourkova IL, Vanyukov MM.

J Neurosci Methods. 2008 Sep 30;174(2):272-80. doi: 10.1016/j.jneumeth.2008.07.018. Epub 2008 Aug 5.

9.

Association between the catechol-O-methyltransferase Val158Met polymorphism and cocaine dependence.

Lohoff FW, Weller AE, Bloch PJ, Nall AH, Ferraro TN, Kampman KM, Pettinati HM, Oslin DW, Dackis CA, O'Brien CP, Berrettini WH.

Neuropsychopharmacology. 2008 Dec;33(13):3078-84. doi: 10.1038/npp.2008.126. Epub 2008 Aug 13.

10.

The neuropsychology of amphetamine and opiate dependence: implications for treatment.

Ersche KD, Sahakian BJ.

Neuropsychol Rev. 2007 Sep;17(3):317-36. Epub 2007 Aug 10. Review.

11.
12.

Correlates of rural methamphetamine and cocaine users: results from a multistate community study.

Booth BM, Leukefeld C, Falck R, Wang J, Carlson R.

J Stud Alcohol. 2006 Jul;67(4):493-501.

PMID:
16736068
13.

Evaluating the comparability of gene expression in blood and brain.

Sullivan PF, Fan C, Perou CM.

Am J Med Genet B Neuropsychiatr Genet. 2006 Apr 5;141B(3):261-8.

PMID:
16526044
14.

Reflection impulsivity in current and former substance users.

Clark L, Robbins TW, Ersche KD, Sahakian BJ.

Biol Psychiatry. 2006 Sep 1;60(5):515-22. Epub 2006 Jan 31.

PMID:
16448627
16.

Neural systems of reinforcement for drug addiction: from actions to habits to compulsion.

Everitt BJ, Robbins TW.

Nat Neurosci. 2005 Nov;8(11):1481-9. Review. Erratum in: Nat Neurosci. 2006 Jul;9(7):979.

PMID:
16251991
17.

Profile of executive and memory function associated with amphetamine and opiate dependence.

Ersche KD, Clark L, London M, Robbins TW, Sahakian BJ.

Neuropsychopharmacology. 2006 May;31(5):1036-47.

18.

Agonist-like, replacement pharmacotherapy for stimulant abuse and dependence.

Grabowski J, Shearer J, Merrill J, Negus SS.

Addict Behav. 2004 Sep;29(7):1439-64. Review.

PMID:
15345275
19.

Association analysis of the DRD4 and COMT genes in methamphetamine abuse.

Li T, Chen CK, Hu X, Ball D, Lin SK, Chen W, Sham PC, Loh el-W, Murray RM, Collier DA.

Am J Med Genet B Neuropsychiatr Genet. 2004 Aug 15;129B(1):120-4.

PMID:
15274053
20.

Supplemental Content

Support Center